Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biopharmaceutical
|
| gptkbp:activeDuring |
somatrogon
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:clinicalTrials |
Phase 3
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| gptkbp:dosageForm |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
NGENLA
|
| gptkbp:mandates |
pediatric growth hormone deficiency
|
| gptkbp:marketedAs |
Ngenla
|
| gptkbp:route |
subcutaneous injection
|
| gptkbp:storage |
refrigerated
|
| gptkbp:usedFor |
treatment of growth hormone deficiency
|